Ligand Pharmaceuticals | Pharmasources.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
  • Ligand Pharmaceuticals agrees to acquire Pfenex for $516m pharmaceutical-technology
    August 12, 2020
    Ligand Pharmaceuticals has entered into a definitive agreement to acquire development and licencing biotechnology firm Pfenex in a deal valued at approximately $516m.
  • Deals this week: Mundipharma, Ligand Pharmaceuticals pharmaceutical-technology
    November 25, 2018
PharmaSources Customer Service